To request an interview with a DCEG investigator, contact the NCI Office of Media Relations:
Get updates on our training programs, scientific openings, and latest research findings on Twitter.
The following are highlighted research findings and scientific papers by DCEG investigators.
February 20, 2019
Mortality patterns among survivors of retinoblastoma differ by hereditary status, cause of death, calendar year of diagnosis, treatment, and time since diagnosis. Study conducted by NCI, Memorial Sloan Kettering Cancer Center, and University of Massachusetts Medical Center.
February 05, 2019
A new report establishes the first quantitative, site-specific risk for benign and malignant tumors in over one hundred individuals with a germline DICER1 pathogenic variant.
January 24, 2019
CHEK2 germline pathogenic variants are associated with a four-to-six times elevated risk for Testicular Germ Cell Tumors (TGCT), and an average age at presentation six years earlier than carriers of wild-type alleles.
January 16, 2019
Researchers in the NCI Division of Cancer Epidemiology and Genetics and collaborators at the National Institutes of Health conducted a formal analysis of overall death rates and death rates from drug poisoning among 25-64-year-olds in the United States. They compared rates across race/ethnicity, socioeconomic status, rurality and geography to determine whether increases in these deaths are limited to poor, rural, white communities in regions with high unemployment.
January 10, 2019
A research team led by investigators from NIH and Global Good has developed a computer algorithm that can analyze digital images of a woman’s cervix and accurately identify precancerous changes that require medical attention.
January 09, 2019
BRCA Exchange is a global resource with data and expert classification on thousands of inherited variants in the BRCA1 and BRCA2 genes that will improve cancer prevention, screening, and intervention for high-risk patients.